Pangenomic Health Inc.
NARA
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 43.30K | 45.50K | 46.20K | 53.80K | 117.90K |
| Gross Profit | -43.30K | -45.50K | -46.20K | -53.80K | -117.90K |
| SG&A Expenses | 83.50K | 111.20K | 111.90K | 300.00K | 143.10K |
| Depreciation & Amortization | 1.50K | 2.30K | 2.30K | 2.30K | 2.30K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 128.00K | 165.90K | 142.50K | 378.60K | 262.20K |
| Operating Income | -128.00K | -165.90K | -142.50K | -378.60K | -262.20K |
| Income Before Tax | -144.90K | -1.86M | -162.30K | -406.40K | -298.50K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -144.90K | -1.86M | -162.30K | -406.40K | -298.50K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -144.90K | -1.86M | -162.30K | -406.40K | -298.50K |
| EBIT | -128.00K | -165.90K | -142.50K | -378.60K | -262.20K |
| EBITDA | -126.40K | -163.60K | -140.20K | -376.30K | -259.80K |
| EPS Basic | -0.02 | -0.33 | -0.08 | -0.20 | -0.15 |
| Normalized Basic EPS | -0.01 | -0.02 | -0.05 | -0.12 | -0.09 |
| EPS Diluted | -0.02 | -0.33 | -0.08 | -0.20 | -0.15 |
| Normalized Diluted EPS | -0.01 | -0.02 | -0.05 | -0.12 | -0.09 |
| Average Basic Shares Outstanding | 6.40M | 5.60M | 2.10M | 2.05M | 1.99M |
| Average Diluted Shares Outstanding | 6.40M | 5.60M | 2.10M | 2.05M | 1.99M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |